| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.26 | 0.2 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.068 | 0.2 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.075 | 0.2 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.075 | 0.2 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |